Non-Alcoholic Fatty Liver Disease and Risk of Macro- and Microvascular Complications in Patients with Type 2 Diabetes
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Non-Alcoholic Fatty Liver Disease and Risk of Macro- and Microvascular Complications in Patients with Type 2 Diabetes
Authors
Keywords
-
Journal
Journal of Clinical Medicine
Volume 11, Issue 4, Pages 968
Publisher
MDPI AG
Online
2022-02-14
DOI
10.3390/jcm11040968
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Risk of Heart Failure in Patients With Nonalcoholic Fatty Liver Disease
- (2022) Alessandro Mantovani et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Association of metabolic dysfunction-associated fatty liver disease with kidney disease
- (2022) Ting-Yao Wang et al. Nature Reviews Nephrology
- Efficacy of peroxisome proliferator-activated receptor agonists, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors for treatment of non-alcoholic fatty liver disease: a systematic review
- (2022) Alessandro Mantovani et al. Lancet Gastroenterology & Hepatology
- Liver Stiffness, Albuminuria and Chronic Kidney Disease in Patients with NAFLD: A Systematic Review and Meta-Analysis
- (2022) Stefano Ciardullo et al. Biomolecules
- Treatments for NAFLD: State of Art
- (2021) Alessandro Mantovani et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A call to action for fatty liver disease
- (2021) Alessandro Mantovani et al. LIVER INTERNATIONAL
- Nonalcoholic Fatty Liver Disease: An Emerging Driver of Cardiac Arrhythmia
- (2021) Ze Chen et al. CIRCULATION RESEARCH
- MAFLD vs NAFLD: Where are we?
- (2021) Alessandro Mantovani DIGESTIVE AND LIVER DISEASE
- Non-alcoholic fatty liver disease is a risk factor for cardiovascular and cardiac diseases: further evidence that a holistic approach to treatment is needed
- (2021) Christopher D Byrne et al. GUT
- Nonalcoholic Fatty Liver Disease and Cardiac Remodeling Risk: Pathophysiological Mechanisms and Clinical Implications
- (2021) Jianghua Zhou et al. HEPATOLOGY
- Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States
- (2021) Donghee Kim et al. JOURNAL OF HEPATOLOGY
- Association between nonalcoholic fatty liver disease and impaired cardiac sympathetic/parasympathetic balance in subjects with and without type 2 diabetes - The Cooperative Health Research in South Tyrol (CHRIS)-NAFLD Substudy
- (2021) Giovanni Targher et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis
- (2021) Alessandro Mantovani et al. Lancet Gastroenterology & Hepatology
- Nonalcoholic fatty liver disease and risk of incident hypertension
- (2021) Stefano Ciardullo et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Aortic valve disease in diabetes: Molecular mechanisms and novel therapies
- (2021) Ileana Manduteanu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Systematically comparing epidemiological and clinical features of MAFLD and NAFLD by meta‐analysis: Focusing on the non‐overlap groups
- (2021) Ibrahim Ayada et al. LIVER INTERNATIONAL
- Risk of cardiovascular events in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis
- (2021) Livnat Alon et al. European Journal of Preventive Cardiology
- Efficacy and safety of anti-hyperglycaemic drugs in patients with non-alcoholic fatty liver disease with or without diabetes: An updated systematic review of randomized controlled trials
- (2020) A. Mantovani et al. DIABETES & METABOLISM
- MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease
- (2020) Mohammed Eslam et al. GASTROENTEROLOGY
- NAFLD as a driver of chronic kidney disease
- (2020) Christopher D. Byrne et al. JOURNAL OF HEPATOLOGY
- PNPLA3 I148M gene variant and Chronic Kidney Disease in Type 2 Diabetic Patients With NAFLD: Clinical and Experimental Findings
- (2020) Alessandro Mantovani et al. LIVER INTERNATIONAL
- Complications, morbidity and mortality of nonalcoholic fatty liver disease
- (2020) Alessandro Mantovani et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Longitudinal Association of Non‐Alcoholic Fatty Liver Disease With Changes in Myocardial Structure and Function: The CARDIA Study
- (2020) Lisa B. VanWagner et al. Journal of the American Heart Association
- Epidemiology and pathophysiology of the association between NAFLD and metabolically healthy or metabolically unhealthy obesity
- (2020) Amedeo Lonardo et al. Annals of Hepatology
- Combination therapy for non-alcoholic steatohepatitis: rationale, opportunities and challenges
- (2020) Jean-François Dufour et al. GUT
- NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications
- (2020) Giovanni Targher et al. GUT
- Nonalcoholic Steatohepatitis
- (2020) Adam C. Sheka et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
- (2020) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- NAFLD, MAFLD and DAFLD
- (2020) Alessandro Mantovani et al. DIGESTIVE AND LIVER DISEASE
- Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort
- (2020) Tracey G Simon et al. GUT
- Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals
- (2020) Alessandro Mantovani et al. GUT
- NAFLD, and cardiovascular and cardiac diseases: Factors influencing risk, prediction and treatment
- (2020) Giovanni Targher et al. DIABETES & METABOLISM
- Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis
- (2020) Alessandro Mantovani et al. GUT
- Association of Non‐alcoholic Fatty Liver Disease with Diabetic Retinopathy in Type 2 Diabetic Patients: A Meta‐Analysis of Observational Studies
- (2020) Dandan Song et al. Journal of Diabetes Investigation
- MAFLD and risk of CKD
- (2020) Dan-Qin Sun et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Association between non-alcoholic fatty liver disease and risk of atrial fibrillation in adult individuals: an updated meta-analysis
- (2019) Alessandro Mantovani et al. LIVER INTERNATIONAL
- The degree of hepatic steatosis associates with impaired cardiac and autonomic function
- (2019) David Houghton et al. JOURNAL OF HEPATOLOGY
- Relationship between PNPLA 3 rs738409 polymorphism and decreased kidney function in children with NAFLD
- (2019) Giovanni Targher et al. HEPATOLOGY
- Evaluation of left atrial function in type 2 diabetes mellitus patients with nonalcoholic fatty liver disease by two-dimensional speckle tracking echocardiography
- (2019) Wenxing Chang et al. ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES
- The Global Epidemiology of NAFLD and NASH in Patients with type 2 diabetes: A Systematic Review and Meta-analysis
- (2019) Zobair M. Younossi et al. JOURNAL OF HEPATOLOGY
- Nonalcoholic fatty liver disease and mortality from all causes, cardiovascular disease, and cancer: a meta-analysis
- (2019) Yan Liu et al. Scientific Reports
- Nonalcoholic fatty liver disease and eGFR levels could be linked by the PNPLA3 I148M polymorphism in children with obesity
- (2019) Pierluigi Marzuillo et al. Pediatric Obesity
- Nonalcoholic Fatty Liver Disease (NAFLD), But not Its Susceptibility Gene Variants, Influences the Decrease of Kidney Function in Overweight/Obese Children
- (2019) Di Costanzo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Risk of kidney dysfunction in NAFLD
- (2019) Alessandro Mantovani et al. CURRENT PHARMACEUTICAL DESIGN
- Liver fibrosis by FibroScan ® independently of established cardiovascular risk parameters associates with macrovascular and microvascular complications in patients with type 2 diabetes
- (2019) Rosa Lombardi et al. LIVER INTERNATIONAL
- PNPLA3 rs738409 is associated with renal glomerular and tubular injury in NAFLD patients with persistently normal ALT levels
- (2019) Dan‐Qin Sun et al. LIVER INTERNATIONAL
- Genetics and epigenetics of NAFLD and NASH: Clinical impact
- (2018) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?
- (2018) Amedeo Lonardo et al. JOURNAL OF HEPATOLOGY
- Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: A systematic review and meta-analysis
- (2018) Alessandro Mantovani et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Expert consensus document: Clinical and molecular diagnosis, screening and management of Beckwith–Wiedemann syndrome: an international consensus statement
- (2018) Frédéric Brioude et al. Nature Reviews Endocrinology
- Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease
- (2018) Quentin M. Anstee et al. Nature Reviews Gastroenterology & Hepatology
- Nonalcoholic fatty liver disease accelerates kidney function decline in patients with chronic kidney disease: a cohort study
- (2018) Hye Ryoun Jang et al. Scientific Reports
- Tests for diagnosing and monitoring non-alcoholic fatty liver disease in adults
- (2018) Christopher D Byrne et al. BMJ-British Medical Journal
- Tests for diagnosing and monitoring non-alcoholic fatty liver disease in adults
- (2018) Christopher D Byrne et al. BMJ-British Medical Journal
- Causality between non-alcoholic fatty liver disease and risk of cardiovascular disease and type 2 diabetes: A meta-analysis with bias analysis
- (2018) Amy E. Morrison et al. LIVER INTERNATIONAL
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- The association between non-alcoholic fatty liver disease and atrial fibrillation: A meta-analysis
- (2017) Karn Wijarnpreecha et al. Clinics and Research in Hepatology and Gastroenterology
- Nonalcoholic fatty liver disease is associated with an increased risk of heart block in hospitalized patients with type 2 diabetes mellitus
- (2017) Alessandro Mantovani et al. PLoS One
- Improvement in liver histology due to lifestyle modification is independently associated with improved kidney function in patients with non-alcoholic steatohepatitis
- (2016) E. Vilar-Gomez et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Nonalcoholic Fatty Liver Disease Is Associated With Ventricular Arrhythmias in Patients With Type 2 Diabetes Referred for Clinically Indicated 24-Hour Holter Monitoring
- (2016) Alessandro Mantovani et al. DIABETES CARE
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- (2016) JOURNAL OF HEPATOLOGY
- Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
- (2016) Giovanni Targher et al. JOURNAL OF HEPATOLOGY
- Assessment of the relationship between non-alcoholic fatty liver disease and diabetic complications
- (2016) Li-hui Yan et al. Journal of Diabetes Investigation
- Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
- (2015) Paul Angulo et al. GASTROENTEROLOGY
- Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up
- (2015) Mattias Ekstedt et al. HEPATOLOGY
- An association of large-fibre peripheral nerve dysfunction with non-invasive measures of liver fibrosis secondary to non-alcoholic fatty liver disease in diabetes
- (2015) Kathryn H. Williams et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- NAFLD: A multisystem disease
- (2015) Christopher D. Byrne et al. JOURNAL OF HEPATOLOGY
- Heart valve calcification in patients with type 2 diabetes and nonalcoholic fatty liver disease
- (2015) Alessandro Mantovani et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Nonalcoholic Fatty Liver Disease Is Independently Associated with Early Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes
- (2015) Alessandro Mantovani et al. PLoS One
- Influence of the PNPLA3 rs738409 Polymorphism on Non-Alcoholic Fatty Liver Disease and Renal Function among Normal Weight Subjects
- (2015) Kentaro Oniki et al. PLoS One
- Association of nonalcoholic fatty liver disease with QTc interval in patients with type 2 diabetes
- (2014) Giovanni Targher et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Nonalcoholic Fatty Liver Disease: A Novel Cardiometabolic Risk Factor for Type 2 Diabetes and Its Complications
- (2013) Giovanni Targher et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
- (2013) Quentin M. Anstee et al. Nature Reviews Gastroenterology & Hepatology
- CGI-58 knockdown sequesters diacylglycerols in lipid droplets/ER-preventing diacylglycerol-mediated hepatic insulin resistance
- (2013) J. L. Cantley et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nonalcoholic fatty liver disease and microvascular complications in type 2 diabetes
- (2013) Wen-Shan Lv WORLD JOURNAL OF GASTROENTEROLOGY
- Prevalences of diabetic retinopathy and nephropathy are lower in Korean type 2 diabetic patients with non-alcoholic fatty liver disease
- (2013) Bo-Yeon Kim et al. Journal of Diabetes Investigation
- Aortic and Mitral Annular Calcifications Are Predictive of All-Cause and Cardiovascular Mortality in Patients With Type 2 Diabetes
- (2012) A. Rossi et al. DIABETES CARE
- Insulin resistance, inflammation, and non-alcoholic fatty liver disease
- (2008) Herbert Tilg et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started